[Federal Register Volume 70, Number 191 (Tuesday, October 4, 2005)]
[Notices]
[Pages 57900-57901]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-19791]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: Nuclear Regulatory Commission.

ACTION: Updated notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting 
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on 
October 25 and 26, 2005. A sample of agenda items to be discussed 
during the public sessions includes: (1) Discussion of the Energy 
policy Act of 2005, which provides for NRC regulation of accelerator-
produced radioactive material and discrete sources of Ra-226; (2) 
Status of Specialty Board applications for NRC recognition; (3) 
Electronic signature in written directives; (4) Revision of NRC Form 
313A; (5) RIS on dose control and assessment; (6) Review of the medical 
events definition commission paper. To review the agenda, see http://www.nrc.gov/reading-rm/doc-collections/acmui/agenda/ or contact, via e-
mail <a href="/cdn-cgi/l/email-protection#e18c9292a18f9382cf868e97"><span class="__cf_email__" data-cfemail="bcd1cfcffcd2cedf92dbd3ca">[email protected]</span></a>.
    Purpose: Discuss issues related to 10 CFR 35, Medical Use of 
Byproduct Material.
    Date and Time for Closed Session Meeting: October 25, 2005, from 8 
a.m. to 11 a.m. This session will be closed so that NRC staff can brief 
the ACMUI on discussing information relating solely to internal 
personnel rules.
    Dates and Times for Public Meetings: October 25, 2005, from 11 a.m. 
to 5 p.m.; and October 26, 2005, from 8 a.m. to 5 p.m.
    Address for Public Meetings: U.S. Nuclear Regulatory Commission, 
Two White Flint North Building, Room

[[Page 57901]]

T2B3, 11545 Rockville Pike, Rockville, MD 20852-2738.

FOR FURTHER INFORMATION CONTACT: Mohammad S. Saba, telephone (301) 415-
7608; e-mail <a href="/cdn-cgi/l/email-protection#a9c4dadae9c7dbca87cec6df"><span class="__cf_email__" data-cfemail="ec819f9fac829e8fc28b839a">[email protected]</span></a> of the Office of Nuclear Material Safety and 
Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC 20555-
0001.

Conduct of the Meeting

    Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit a 
reproducible copy to Mohammad S. Saba, U.S. Nuclear Regulatory 
Commission, Mail Stop T8F03, Washington, DC 20555. Alternatively, an e-
mail can be submitted to <a href="/cdn-cgi/l/email-protection#a9c4dadae9c7dbca87cec6df"><span class="__cf_email__" data-cfemail="305d4343705e42531e575f46">[email protected]</span></a>. Submittals must be postmarked or 
emailed by October 3, 2005 and must pertain to the topics on the agenda 
for the meeting.
    2. Questions from members of the public will be permitted during 
the meeting, at the discretion of the Chairman.
    3. The transcript and written comments will be available for 
inspection on NRC's Web site (www.nrc.gov) and at the NRC Public 
Document Room, 11555 Rockville Pike, Rockville, MD 20852-2738, 
telephone (800) 397-4209, on or about January 26, 2006. This meeting 
will be held in accordance with the Atomic Energy Act of 1954, as 
amended (primarily Section 161a); the Federal Advisory Committee Act (5 
U.S.C. App); and the Commission's regulations in Title 10, U.S. Code of 
Federal Regulations, Part 7.
    4. Attendees are requested to notify Mohammad S. Saba at (301) 415-
7608 of their planned attendance if special services, such as for the 
hearing impaired, are necessary.

    Dated at Rockville, Maryland, this 29th day of September, 2005.

    For the Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 05-19791 Filed 10-3-05; 8:45 am]
BILLING CODE 7590-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>